B. Antelo Rodríguez

发表

Improved personalized survival prediction of patients with diffuse large B-cell Lymphoma using gene expression profiling

J. D. Díaz Arias, N. Alonso Vence, M. S. González Pérez, 2020, BMC Cancer.

New Recurrent Structural Aberrations in the Genome of Chronic Lymphocytic Leukemia Based on Exome-Sequencing Data

J. D. Díaz Arias, M. S. González Pérez, J. B. Bello López, 2019, Front. Genet..

Prognostic Stratification of Multiple Myeloma Using Clinicogenomic Models: Validation and Performance Analysis of the IAC-50 Model

M. Mateos, J. D. Díaz Arias, M. S. González Pérez, 2022, HemaSphere.

Detection of Rare Germline Variants in the Genomes of B Cell Neoplasms

J. D. Díaz Arias, N. Alonso Vence, M. S. González Pérez, 2021 .

Evaluation of the Stellae-123 prognostic gene expression signature in acute myeloid leukemia

G. Martinelli, C. Cerchione, A. de la Fuente Burguera, 2022, Frontiers in Oncology.

Detection of Rare Germline Variants in the Genomes of Patients with B-Cell Neoplasms

J. D. Díaz Arias, N. Alonso Vence, M. S. González Pérez, 2021, Cancers.

The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution

J. D. Díaz Arias, N. Alonso Vence, J. B. Bello López, 2019, BMC cancer.

FLT3 inhibitors in the treatment of Acute Myeloid Leukemia: current status and future perspectives.

G. Martinelli, C. Cerchione, J. D. Díaz Arias, 2020, Minerva medica.

Time to Treatment Prediction in Chronic Lymphocytic Leukemia Based on New Transcriptional Patterns

J. D. Díaz Arias, N. Alonso Vence, M. S. González Pérez, 2019, Front. Oncol..

Identification of new putative driver mutations and predictors of disease evolution in chronic lymphocytic leukemia

J. D. Díaz Arias, J. B. Bello López, A. Mosquera Orgueira, 2019, Blood Cancer Journal.

Detection of new drivers of frequent B-cell lymphoid neoplasms using an integrated analysis of whole genomes

J. D. Díaz Arias, N. Alonso Vence, M. S. González Pérez, 2021, PloS one.

Survival prediction and treatment optimization of multiple myeloma patients using machine-learning models based on clinical and gene expression data

J. D. Díaz Arias, N. Alonso Vence, M. S. González Pérez, 2021, Leukemia.

A Three-Gene Expression Signature Identifies a Cluster of Patients with Short Survival in Chronic Lymphocytic Leukemia

J. D. Díaz Arias, J. B. Bello López, N. Díaz Varela, 2019, Journal of oncology.

Gene expression profiling identifies FLT3 mutation-like cases in wild-type FLT3 acute myeloid leukemia

G. Martinelli, C. Cerchione, J. D. Díaz Arias, 2021, PloS one.

Personalized Survival Prediction of Patients With Acute Myeloblastic Leukemia Using Gene Expression Profiling

C. Cerchione, J. D. Díaz Arias, N. Alonso Vence, 2021, Frontiers in Oncology.

Personally Tailored Survival Prediction of Patients With Follicular Lymphoma Using Machine Learning Transcriptome-Based Models

P. Mozas, C. Cerchione, J. D. Díaz Arias, 2022, Frontiers in Oncology.

Prognostic Stratification of Diffuse Large B-cell Lymphoma Using Clinico-genomic Models: Validation and Improvement of the LymForest-25 Model

J. D. Díaz Arias, M. S. González Pérez, J. B. Bello López, 2022, HemaSphere.

The association of germline variants with chronic lymphocytic leukemia outcome suggests the implication of novel genes and pathways in clinical evolution

J. D. Díaz Arias, N. Alonso Vence, J. B. Bello López, 2019, BMC Cancer.